Search research articles
Contact Us
Filters
Showing results (31-40 of 124) with videos related to
Page
of 13
Sort By:
Frontiers in Molecular Biosciences
|
June 30, 2022
Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
Xiulin Jiang, Xi Chen, Jishu Guo, et al.
Journal of Cellular and Molecular Medicine
|
May 9, 2012
Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening
Elia Ranzato, Simona Martinotti, Valeria Magnelli, et al.
Plos Computational Biology
|
November 7, 2017
Insight into glucocorticoid receptor signalling through interactome model analysis
Emyr Bakker, Kun Tian, Luciano Mutti, et al.
Genes & Cancer
|
February 14, 2017
Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
Noushin Nabavi, Kevin L Bennewith, Andrew Churg, et al.
International Journal of Molecular Sciences
|
July 29, 2020
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy
Pierpaolo Correale, Luciano Mutti, Francesca Pentimalli, et al.
International Journal of Molecular Sciences
|
January 24, 2019
<i>BAP1</i> Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
Alice Guazzelli, Parisa Meysami, Emyr Bakker, et al.
Expert Opinion on Investigational Drugs
|
July 3, 2019
What can independent research for mesothelioma achieve to treat this orphan disease?
Alice Guazzelli, Parisa Meysami, Emyr Bakker, et al.
Journal of Cellular Physiology
|
September 5, 2002
Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines
Salvatore Toma, Lucia Colucci, Linda Scarabelli, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2005
Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients
Camillo Porta, Matteo Zimatore, Lucia Bonomi, et al.
Cancer Research
|
June 17, 2005
SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure
Paola Cacciotti, Dario Barbone, Camillo Porta, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 124) with videos related to
Sort By:
Page
of 13
Frontiers in Molecular Biosciences
|
June 30, 2022
Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
Xiulin Jiang, Xi Chen, Jishu Guo, et al.
Journal of Cellular and Molecular Medicine
|
May 9, 2012
Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening
Elia Ranzato, Simona Martinotti, Valeria Magnelli, et al.
Plos Computational Biology
|
November 7, 2017
Insight into glucocorticoid receptor signalling through interactome model analysis
Emyr Bakker, Kun Tian, Luciano Mutti, et al.
Genes & Cancer
|
February 14, 2017
Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
Noushin Nabavi, Kevin L Bennewith, Andrew Churg, et al.
International Journal of Molecular Sciences
|
July 29, 2020
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy
Pierpaolo Correale, Luciano Mutti, Francesca Pentimalli, et al.
International Journal of Molecular Sciences
|
January 24, 2019
<i>BAP1</i> Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
Alice Guazzelli, Parisa Meysami, Emyr Bakker, et al.
Expert Opinion on Investigational Drugs
|
July 3, 2019
What can independent research for mesothelioma achieve to treat this orphan disease?
Alice Guazzelli, Parisa Meysami, Emyr Bakker, et al.
Journal of Cellular Physiology
|
September 5, 2002
Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines
Salvatore Toma, Lucia Colucci, Linda Scarabelli, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2005
Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients
Camillo Porta, Matteo Zimatore, Lucia Bonomi, et al.
Cancer Research
|
June 17, 2005
SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure
Paola Cacciotti, Dario Barbone, Camillo Porta, et al.
Page
of 13